Cellectar Biosciences Inc (NASDAQ:CLRB) does about 799.01K shares in volume on a normal day but saw 1164222 shares change hands in Friday’s trading. The company now has a market cap of 119.38M USD. Its current market price is $3.33, marking an increase of 9.90% compared to the previous close of $3.03. The 52 week high reached by this stock is $4.45 whilst the lowest price level in 52 weeks is $1.56.
Cellectar Biosciences Inc (CLRB) has a 20-day trading average at $3.12 and the current price is -25.17% off the 52-week high compared with 113.43% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.29 and its 200-day simple moving average is $2.98. If we look at the stock’s price movements over the week, volatility stands at 7.49%, which decreases to 5.69% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.20 to suggest the stock is neutral.
The consensus objective for the share price is $15.25, suggesting that the stock has a potential upside of 78.16% over the period.
Cellectar Biosciences Inc (CLRB) stock is up 7.77% over the week and 4.06% over the past month. Its price is 20.22% year-to-date and 84.79% over the past year.
To reach the target analysts have set, the stock logically needs to grow 78.16 percent from here.
The company has a return on investment of -191.38% and return on equity of -304.38%. The beta has a value of 1.02. Price to book ratio is 12.15.
